On the 26th, Osang Healthcare announced that it had signed a share investment agreement with Allez Health (herein after referred to as Allez Health), a US company developing continuous glucose monitoring devices, and had paid the investment funds.
Allez Health is a US venture company founded in 2018 that is developing continuous glucose monitoring devices with the goal of innovating diabetes management technology. Osang Healthcare has closely monitored Allez Health's research and development process since its founding and has developed a close relationship with the company, leading to the current Series A+ investment.
Osang Healthcare has invested approximately $36 million in Allez Health, which is preparing for clinical trials for FDA approval, with $22.5 million to be paid immediately and the remaining amount to be paid in installments.